The U.S. Centers for Disease Control and Prevention (CDC) has recently updated its guidance on hepatitis B vaccination for infants, reflecting a shift away from a one-size-fits-all model toward a more individualized, risk-based approach.
For more than 30 years, the CDC recommended that all newborns receive the hepatitis B vaccine shortly after birth, regardless of personal or environmental risk factors. Today, advances in prenatal screening mean that most maternal hepatitis B infections are identified well before delivery. With clearer information available earlier, the CDC now recognizes that vaccination timing can be tailored when an infant’s risk is clearly low.
Through the MAHA movement, Robert F. Kennedy Jr. has brought renewed attention to informed consent and whole-body, root-cause approaches to health—moving away from standardized protocols that may not reflect individual needs.
Under the new recommendations:
- Infants born to mothers who test positive for hepatitis B, or whose status is unknown, should continue to receive the hepatitis B vaccine and immune globulin at birth. This remains a critical and time-sensitive medical intervention.
- Infants born to mothers who test negative for hepatitis B during pregnancy have more freedom to now choose—in collaboration with their healthcare provider—to:
- Receive the first hepatitis B vaccine dose at birth, or
- Delay the first dose until 2 months of age or later
This update replaces an automatic universal recommendation with a more personalized option for families considered at lower risk.
At Active Edge, we focus on understanding risk at its source rather than applying blanket protocols. Our approach emphasizes:
-
- Evaluating household, lifestyle, and environmental exposure risks
- Supporting the body’s innate capacity for balance and resilience
- Ensuring patients feel educated, empowered, and supported, not rushed or pressured
We believe thoughtful medical decisions are best made when families understand why an intervention is recommended, when it is most appropriate, and how it fits into their broader health picture. This updated CDC guidance reinforces what we prioritize at Active Edge: root-cause evaluation, personalized care, informed consent, and thoughtful decision-making—rather than fear based or automatic choices.